ID: ALA3719254

Max Phase: Preclinical

Molecular Formula: C20H18ClNO5

Molecular Weight: 387.82

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)CC(=O)NC1(C(=O)O)Cc2ccc(-c3ccc(Cl)cc3)cc2C1

Standard InChI:  InChI=1S/C20H18ClNO5/c1-27-18(24)9-17(23)22-20(19(25)26)10-14-3-2-13(8-15(14)11-20)12-4-6-16(21)7-5-12/h2-8H,9-11H2,1H3,(H,22,23)(H,25,26)

Standard InChI Key:  CPAGCMZOWOMHJA-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.82Molecular Weight (Monoisotopic): 387.0874AlogP: 2.61#Rotatable Bonds: 5
Polar Surface Area: 92.70Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.70CX Basic pKa: CX LogP: 3.30CX LogD: -0.01
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -0.38

References

1.  (2010)  Regulating agent of GPR34 receptor function, 

Source